• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Subretinal tissue plasminogen activator injection to treat submacular haemorrhage during age-related macular degeneration.

作者信息

Dewilde Evelien, Delaere Lien, Vaninbroukx Isaline, Van Calster Joachim, Stalmans Peter

机构信息

Department of Opthalmology, University Hospitals Leuven, Leuven, Belgium.

出版信息

Acta Ophthalmol. 2014 Sep;92(6):e497-8. doi: 10.1111/aos.12458. Epub 2014 Jun 18.

DOI:10.1111/aos.12458
PMID:24943231
Abstract
摘要

相似文献

1
Subretinal tissue plasminogen activator injection to treat submacular haemorrhage during age-related macular degeneration.视网膜下注射组织型纤溶酶原激活剂治疗年龄相关性黄斑变性中的黄斑下出血。
Acta Ophthalmol. 2014 Sep;92(6):e497-8. doi: 10.1111/aos.12458. Epub 2014 Jun 18.
2
Management of thick submacular hemorrhage with subretinal tissue plasminogen activator and pneumatic displacement for age-related macular degeneration.应用组织型纤溶酶原激活物(subretinal tissue plasminogen activator, srt-PA)和空气动力学移位(subretinal tissue plasminogen activator, srt-PA)治疗年龄相关性黄斑变性的厚型脉络膜下出血的管理。
Am J Ophthalmol. 2014 Jun;157(6):1250-7. doi: 10.1016/j.ajo.2014.02.007. Epub 2014 Feb 13.
3
Submacular hemorrhage in polypoidal choroidal vasculopathy treated by vitrectomy and subretinal tissue plasminogen activator.玻璃体切除术联合视网膜下组织型纤溶酶原激活剂治疗息肉样脉络膜血管病变所致黄斑下出血
Am J Ophthalmol. 2015 Apr;159(4):683-9. doi: 10.1016/j.ajo.2014.12.020. Epub 2014 Dec 30.
4
Intravitreal tissue plasminogen activator, perfluoropropane (C3F8), and ranibizumab or photodynamic therapy for submacular hemorrhage secondary to wet age-related macular degeneration.眼内组织型纤溶酶原激活物、全氟丙烷（C3F8）以及雷珠单抗或光动力疗法治疗湿性年龄相关性黄斑变性继发的黄斑下出血。
Retina. 2013 Apr;33(4):846-53. doi: 10.1097/IAE.0b013e318271f278.
5
Vitrectomy with subretinal tissue plasminogen activator and ranibizumab for submacular haemorrhages secondary to age-related macular degeneration: retrospective case series of 45 consecutive cases.玻璃体切除术联合视网膜下组织型纤溶酶原激活剂和雷珠单抗治疗年龄相关性黄斑变性继发黄斑下出血：45例连续病例的回顾性病例系列研究
Eye (Lond). 2016 Jul;30(7):929-35. doi: 10.1038/eye.2016.65. Epub 2016 Apr 8.
6
Efficacy and safety of recombinant tissue plasminogen activator and gas versus bevacizumab and gas for subretinal haemorrhage.重组组织型纤溶酶原激活物与气体和贝伐单抗与气体治疗视网膜下出血的疗效和安全性。
Acta Ophthalmol. 2013 May;91(3):274-8. doi: 10.1111/j.1755-3768.2011.02264.x. Epub 2011 Sep 22.
7
Early treatment of acute submacular haemorrhage secondary to wet AMD using intravitreal tissue plasminogen activator, C3F8, and an anti-VEGF agent.使用玻璃体内组织型纤溶酶原激活剂、C3F8和抗血管内皮生长因子药物对湿性年龄相关性黄斑变性继发的急性黄斑下出血进行早期治疗。
Eye (Lond). 2016 Jul;30(7):952-7. doi: 10.1038/eye.2016.67. Epub 2016 Apr 15.
8
Submacular combination treatment for management of acute, massive submacular hemorrhage in age-related macular degeneration.黄斑下联合治疗用于年龄相关性黄斑变性急性大量黄斑下出血的管理
Ophthalmic Surg Lasers Imaging. 2009 May-Jun;40(3):308-15. doi: 10.3928/15428877-20090430-16.
9
Effects of intravitreal gas with or without tissue plasminogen activator on submacular haemorrhage in age-related macular degeneration.玻璃体内气体联合或不联合组织型纤溶酶原激活剂治疗年龄相关性黄斑变性伴脉络膜下出血的效果。
Eye (Lond). 2009 Feb;23(2):397-406. doi: 10.1038/sj.eye.6703017. Epub 2007 Nov 2.
10
Long-term outcome of subretinal coapplication of rtPA and bevacizumab followed by repeated intravitreal anti-VEGF injections for neovascular AMD with submacular haemorrhage.rtPA 和贝伐单抗联合应用于伴有黄斑下出血的新生血管性 AMD 并重复玻璃体内抗 VEGF 注射的长期疗效。
Br J Ophthalmol. 2012 May;96(5):708-13. doi: 10.1136/bjophthalmol-2011-300655. Epub 2011 Dec 15.

引用本文的文献

1
Tissue plasminogen activator-assisted vitrectomy for submacular hemorrhage due to age-related macular degeneration.组织型纤溶酶原激活剂辅助玻璃体切除术治疗年龄相关性黄斑变性所致黄斑下出血
Indian J Ophthalmol. 2017 Jun;65(6):482-487. doi: 10.4103/ijo.IJO_129_16.